Boeing Rises 1% to $238.17 After Jefferies Flags Positive Trump Post
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3d ago
0mins
Should l Buy BA?
Boeing up 1% to $238.17 after Jefferies flags positive Trump post
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BA
Wall Street analysts forecast BA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BA is 252.43 USD with a low forecast of 150.00 USD and a high forecast of 285.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
14 Buy
2 Hold
1 Sell
Strong Buy
Current: 236.950
Low
150.00
Averages
252.43
High
285.00
Current: 236.950
Low
150.00
Averages
252.43
High
285.00
About BA
The Boeing Company is an aerospace company. Its segments include Commercial Airplanes (BCA), Defense, Space & Security (BDS), and Global Services (BGS). Its BCA segment develops, produces and markets commercial jet aircraft principally for the commercial airline industry worldwide. Its family of commercial jet aircraft in production includes the 737 narrow-body model and the 767, 777 and 787 wide-body models. Its BDS segment is engaged in the research, development, production and modification of manned and unmanned military aircraft and weapons systems for strike, surveillance and mobility. Its BGS segment provides services to its commercial and defense customers worldwide. It sustains aerospace platforms and systems with a range of products and services, including supply chain and logistics management, engineering, maintenance and modifications, upgrades and conversions, spare parts, pilot and maintenance training systems and services, technical and maintenance documents, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Dow Index Milestone: The Dow Jones Industrial Average has surpassed 50,000 for the first time, marking a significant recovery in the U.S. stock market, reflecting increased investor confidence in economic recovery, which may lead to more capital inflows into equities.
- Buying Opportunities: Stocks like JPMorgan, Apple, and Boeing have entered buy zones, indicating that the performance of these large companies has attracted investor interest, potentially driving their stock prices higher and enhancing market vitality.
- Nasdaq Divergence: While the Nasdaq remains below key support levels, some AI-related stocks are reviving, indicating a potential rebound in tech stocks that may provide new investment opportunities for investors.
- Market Sentiment Improvement: The overall market sentiment is improving, as optimistic expectations for future economic growth may encourage more capital to flow into the stock market, thereby driving further increases in the overall market.
See More
- Dow Jones Milestone: The Dow Jones Industrial Average has surpassed 50,000 for the first time, indicating a significant boost in market confidence that could attract more investors and drive overall economic recovery.
- Key Stock Performance: Stocks like JPMorgan, Apple, and Boeing are now in buy zones, reflecting their strong fundamentals and market demand, which may further propel their stock prices and enhance investor confidence.
- Nasdaq Divergence: While the Nasdaq remains below key support levels, certain AI stocks are reviving, suggesting a renewed interest in tech stocks that could lay the groundwork for future growth.
- Improved Market Sentiment: The Dow's breakthrough not only reflects optimistic expectations for economic recovery but may also encourage other indices to follow suit, further enhancing overall market vitality and liquidity.
See More
- Dow Jones Milestone: The Dow Jones Industrial Average has surpassed 50,000 for the first time, marking a significant recovery in the U.S. stock market and reflecting increased investor confidence in economic recovery, which may lead to more capital inflows.
- Key Stock Performance: Stocks like JPMorgan, Apple, and Boeing have entered buy zones, indicating strong market performance and potentially attracting more investor interest, which could further drive up their stock prices.
- Nasdaq Weakness: While the Nasdaq index is struggling, certain AI stocks are experiencing a revival, suggesting a divergence in tech stock performance that may present new investment opportunities for investors.
- Market Sentiment Shift: The Dow's breakthrough could shift market sentiment, drawing in more investors and impacting overall market liquidity and investment strategies, thereby further propelling economic recovery.
See More

Stock Market Surge: The stock market experienced a significant rebound, with the Dow Jones Industrial Average increasing by over 1,000 points.
Historic Milestone: This surge allowed the Dow to surpass the 50,000 mark for the first time in history.
See More
Market Performance: The stock market experienced a significant rebound, with the Dow Jones Industrial Average increasing by over 1,000 points.
Historic Milestone: This surge pushed the Dow above 50,000 for the first time in history.
See More
- Dow Jones Rebound: On Friday, the Dow Jones surged over 950 points, nearly 2%, indicating a strong market rebound, which Jim Cramer described as a 'mighty Dow rally', boosting investor sentiment.
- Amazon Stock Decline: Despite the overall rise in Dow components, Amazon's stock fell 7.5% due to massive spending plans and weaker-than-expected guidance revealed in Thursday's earnings report, impacting investor confidence.
- Eli Lilly Share Recovery: Eli Lilly shares bounced back 3% on Friday after an almost 8% drop, as the FDA announced actions against illegal copycat drugs, which bolstered market confidence in Lilly's growth potential.
- Linde Rating Downgrade: Following a 2.9% decline post-earnings on Thursday, Linde shares dropped another 1.7% on Friday after JPMorgan downgraded its rating to hold, although Jim Cramer maintained a buy rating and raised the price target to $510.
See More










